Spexis AG (XSWX:SPEX) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Spexis AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Spexis AG's Free Cash Flow for the six months ended in Dec. 2023 was CHF-2.38 Mil. Spexis AG's Revenue for the six months ended in Dec. 2023 was CHF0.00 Mil. Therefore, Spexis AG's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Spexis AG's current FCF Yield % is -147.23%.

The historical rank and industry rank for Spexis AG's FCF Margin % or its related term are showing as below:

During the past 11 years, the highest FCF Margin % of Spexis AG was -219.45%. The lowest was -565080.00%. And the median was -533.78%.

XSWX:SPEX's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.2
* Ranked among companies with meaningful FCF Margin % only.

Spexis AG FCF Margin % Historical Data

The historical data trend for Spexis AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spexis AG FCF Margin % Chart

Spexis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-565,080.00

Spexis AG Semi-Annual Data
	Dec13	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of Spexis AG's FCF Margin %

For the Biotechnology subindustry, Spexis AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spexis AG's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spexis AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Spexis AG's FCF Margin % falls into.

Spexis AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Spexis AG's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-5.481	/	0
	=	%

Spexis AG's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-2.379	/	0
	=	%

Spexis AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of Spexis AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Spexis AG (XSWX:SPEX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (XSWX:SPEX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SPEXz:UK

Address

Hegenheimermattweg 125, Allschwil, CHE, CH-4123

Website

https://www.polyphor.com

Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (XSWX:SPEX) Headlines

No Headlines